Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product By: CNBC.com News May 31, 2024 at 11:09 AM EDT The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product By: CNBC.com News May 31, 2024 at 11:09 AM EDT The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product. Read More >>